>
NEW: The New 28-Point Peace Plan for the Russia-Ukraine War by the Trump Administration Leaks...
See Spot Terminate: Police Increase Use Of Robot Dogs For Law Enforcement
RFK Jr. Says Government Going To Figure Out What's Causing Food Allergies
Why Steven Grayhm's New Movie Sheepdog Is Worth The Wait | #459 | The Way I Heard It
New Gel Regrows Dental Enamel–Which Humans Cannot Do–and Could Revolutionize Tooth Care
Researchers want to drop lab grown brains into video games
Scientists achieve breakthrough in Quantum satellite uplink
Blue Origin New Glenn 2 Next Launch and How Many Launches in 2026 and 2027
China's thorium reactor aims to fuse power and parity
Ancient way to create penicillin, a medicine from ancient era
Goodbye, Cavities? Scientists Just Found a Way to Regrow Tooth Enamel
Scientists Say They've Figured Out How to Transcribe Your Thoughts From an MRI Scan
Calling Dr. Grok. Can AI Do Better than Your Primary Physician?

The US processed-food industrial complex, partly controlled by globalist mega-corps, is beginning to reckon with a new reality: Make America Healthy Again and rising weight-loss drug use are reshaping what Americans eat - and what they're walking away from, mostly junk food loaded with toxic seed oils, as well as alcohol.
In the coming weeks, Robert F. Kennedy Jr., President Donald Trump's Health and Human Services (HHS) Secretary, will be releasing new dietary guidelines to reset America's food supply chain away from toxic seed oils and highly processed foods toward real food. This is part of the MAHA trend.
MAHA, combined with the expected surge in GLP-1 demand (thanks to Trump's deal with Novo Nordisk and Lilly to cut costs), is likely to wipe out tens of billions in food and beverage sales in the coming years.
Bloomberg Intelligence analysts Jibril Lawal and Jennifer Bartashus forecast that the rapid adoption of GLP-1 weight-loss drugs will reduce US and European food and beverage sales by $53 billion by 2035.
Weight-loss drugs are reshaping consumption, and our analysis shows GLP-1s are set to erase $53 billion in food and beverage sales by 2035. Volume losses will be steepest in snacks, baked goods and confectionery -- a 4-6% sales drag in the US and 3-5% in Europe. Alcohol also faces a 2-4% drop as consumers shift to healthier options. -Lawal
Here are the key takeaways from the report that only suggest a coming food revolution across the West:
1. GLP-1s Could Cut Food, Beverage Sales by Billions
The adoption of GLP-1 drugs will significantly reduce US and European food and beverage consumption if uptake reaches 19.5% and 13.1% of the adolescent and adult population (ages 12-65+) by 2035, BI's high-end scenario analysis shows. Our model isolates volume impact only and excludes pricing increases or reformulations that might o?set lower consumption. Under these assumptions, baked-goods sales are expected to drop by $11.5 billion and confectionery $8 billion -- the largest food declines -- while beer and spirits may fall by $12.5 billion and $9.2 billion, the steepest beverage contractions. Concurrently, we anticipate demand to shift toward healthier alternatives, with bottled water, fruits and vegetables each gaining more than $4 billion over the period.